
Introduction
Klotho is a transmembrane protein and circulating hormone-like molecule that has emerged as one of the most significant regulators of aging biology. First identified in 1997, the Klotho gene was named after the Greek Fate who spins the thread of life. Experimental models have shown that disruption of Klotho expression accelerates aging phenotypes, while increased expression extends lifespan and improves metabolic resilience.
Klotho exists in both membrane-bound and soluble forms. The membrane-bound form functions as a co-receptor for fibroblast growth factor 23 (FGF23), while the soluble form acts systemically, influencing oxidative stress, insulin signaling, inflammation, and cellular repair mechanisms. Because of its broad biological influence, Klotho is now considered a central node in longevity research.
Molecular Structure and Isoforms
The Klotho gene (KL) encodes a single-pass transmembrane protein primarily expressed in the kidney, brain (especially the choroid plexus), and parathyroid gland. Two major forms exist:
• Membrane-bound α-Klotho – Functions as an obligate co-receptor for FGF23.
• Soluble Klotho – Generated either by alternative splicing or ectodomain shedding.
The soluble form circulates in blood, cerebrospinal fluid, and urine, exerting endocrine-like effects across multiple organ systems.
FGF23–Klotho Axis
The most well-characterized function of Klotho is its role in phosphate and vitamin D metabolism through the FGF23 axis. Klotho binds to fibroblast growth factor receptors (FGFRs), increasing their affinity for FGF23. This interaction regulates:
• Phosphate excretion in the kidney
• Vitamin D activation
• Calcium balance
Disruption of this axis leads to hyperphosphatemia, vascular calcification, and accelerated aging phenotypes in animal models.
Metabolic Regulation and Insulin Signaling
Klotho modulates insulin and IGF-1 signaling pathways. It has been shown to attenuate insulin receptor signaling under certain conditions, promoting metabolic flexibility and reducing excessive anabolic signaling.
Excessive IGF-1 signaling is associated with accelerated aging in multiple model organisms. Klotho appears to exert a protective effect by dampening this pathway, thereby promoting cellular stress resistance and improved metabolic efficiency.
Oxidative Stress and Cellular Protection
One of Klotho’s most important protective functions is its ability to reduce oxidative stress. It enhances the expression of antioxidant enzymes such as manganese superoxide dismutase (MnSOD) and catalase.
Mechanistically, Klotho influences the FOXO transcription factors, which regulate cellular stress response genes. Through this pathway, Klotho supports mitochondrial integrity and reduces reactive oxygen species (ROS) accumulation.
Neurological Implications
High Klotho expression is associated with improved cognitive performance and neuroprotection. In preclinical models, elevated Klotho levels correlate with:
• Enhanced synaptic plasticity
• Increased NMDA receptor function
• Reduced neuroinflammation
Lower circulating Klotho levels have been associated with cognitive decline and neurodegenerative disease progression.
Cardiovascular and Renal Effects
Because Klotho is primarily expressed in the kidney, its decline is closely linked to chronic kidney disease (CKD). Reduced Klotho levels contribute to vascular calcification, endothelial dysfunction, and accelerated cardiovascular aging.
Restoration of Klotho signaling in experimental models reduces arterial stiffness and improves endothelial nitric oxide production.
Klotho and Longevity Research
Animal studies have shown that Klotho overexpression extends lifespan, while deficiency accelerates aging. Hallmarks influenced by Klotho include:
• Genomic stability
• Proteostasis
• Nutrient sensing
• Mitochondrial function
• Inflammation
These effects position Klotho as a master regulator within aging biology frameworks.
Translational Considerations
Despite strong preclinical data, direct Klotho-based therapies remain under investigation. Approaches being studied include:
• Gene therapy vectors
• Recombinant soluble Klotho protein
• Small molecules that upregulate endogenous Klotho expression
Human clinical translation is still limited, and further research is required to determine therapeutic feasibility.
Conclusion
Klotho represents one of the most compelling molecular regulators in longevity science. Through its interaction with FGF23, modulation of insulin signaling, protection against oxidative stress, and neuroprotective effects, it integrates multiple aging-related pathways.
While human interventional data remain limited, the mechanistic foundation supporting Klotho’s role in cellular resilience and lifespan regulation is robust. Ongoing research will determine whether Klotho modulation becomes a viable strategy for age-related disease intervention.
Selected References
Kuro-o M. et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997.
Kurosu H. et al. Regulation of fibroblast growth factor-23 signaling by Klotho. J Biol Chem. 2006.
Dubal DB. et al. Life extension factor Klotho enhances cognition. Cell Reports. 2014.
Semba RD. et al. Plasma Klotho and mortality risk in older adults. J Gerontol A Biol Sci Med Sci. 2011.
Hu MC. et al. Klotho deficiency causes vascular calcification. J Am Soc Nephrol. 2011.
Klotho is a transmembrane protein that also exists in a soluble circulating form, acting as a regulator of aging-related and metabolic signaling pathways.
Klotho is mainly expressed in the kidneys and brain, with additional activity observed in endocrine-related tissues.
Klotho is involved in phosphate regulation, oxidative stress control, and modulation of key metabolic and cellular signaling pathways.
Klotho functions as a co-receptor for FGF23, enabling proper regulation of phosphate and vitamin D metabolism.
Research models show that increased Klotho expression is associated with extended lifespan and improved metabolic resilience.
Klotho has been shown to influence insulin and IGF-1 signaling pathways, which are closely tied to energy metabolism.
Research suggests Klotho plays a role in cognitive function, synaptic activity, and overall brain resilience.
Reduced Klotho levels have been associated with aging-related changes, including impaired metabolic regulation and kidney function.
Klotho demonstrates antioxidant-related activity in research models, helping reduce oxidative stress and cellular damage.
Klotho is being investigated for its role in regulating multiple pathways linked to aging, metabolism, and cellular resilience.
PMID: 12845331 — Klotho: a gene involved in aging suppression and metabolic regulation
PMID: 15502873 — Klotho protein and its role in phosphate and vitamin D metabolism
PMID: 16815323 — Regulation of insulin/IGF-1 signaling by Klotho and implications for longevity
PMID: 20376082 — Klotho as a circulating hormone influencing oxidative stress and cellular function
PMID: 21623367 — Klotho and its neuroprotective effects in brain aging models
PMID: 22982849 — Role of Klotho in kidney function and mineral metabolism
PMID: 25411277 — Molecular mechanisms of Klotho in aging and disease pathways
PMID: 27346346 — Klotho regulation of oxidative stress and mitochondrial function
PMID: 28502463 — Klotho and its involvement in metabolic and endocrine signaling
PMID: 30069088 — Emerging roles of Klotho in longevity and age-related biological processes
Tirzepatide: Dual GIP and GLP-1 Receptor Agonism and Integrated Incretin Pathway Signaling
Semaglutide : GLP-1 Receptor Agonism, Incretin Signaling, and Metabolic Regulation
Orforglipron : Oral Small-Molecule GLP-1 Receptor Agonist and Incretin Pathway Modulation